A Phase 4 interventional study of Oxytocin after delivery and Intraumbilical oxytocin in Postpartum Bleeding, Oxytocin and Third Stage of Labour, sponsored by CMH Multan Institute of Medical Sciences. Completed at 1 site in Pakistan. Open to female participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-05-05.
Sponsored by CMH Multan Institute of Medical Sciences · Phase 4, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Postpartum Hemorrhage with a site in Pakistan — 4 open to participants now, 4 under way, none of them phase 3. Postpartum Hemorrhage · Pakistan.
Among the 17 studies in Postpartum Hemorrhage with a site in Pakistan, this one is the 13th largest by enrollment of the 16 interventional ones that give a count, is one of 2 that started in 2025, is the only one in phase 4, and was the 15th registered.
471 studies on the registry are indexed under Postpartum Hemorrhage; 76 are open to participants now.
Browse Postpartum Hemorrhage studies →4 of the 17 studies in Postpartum Hemorrhage with a site in Pakistan are open now. Recruiting first, the newest first:
Aziz Fatimah Medical & Dental College, Faisalabad · Sites in Pakistan
Ages 18–35 · Women only
Khyber Girls Medical College · Sites in Pakistan
Ages 18–40 · Women only
Pak Emirates Military Hospital · Sites in Pakistan
Ages 18–45 · Women only · Healthy volunteers
Patel Hospital, Pakistan · Sites in Pakistan
Ages 18–45 · Women only · Healthy volunteers
A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →
Of the 41 Postpartum Hemorrhage studies recruiting now, 21 (51%) set no upper age limit and 20 (49%) stop at 75 or younger; 6 take children under 18; 20 take healthy volunteers.
This study: 20 Years to 40 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 60 is below the median of 148 across 362 interventional studies indexed under Postpartum Hemorrhage.
Median enrollment 181 across the 16 interventional studies, 121 across the 1 observational. Of the 11 that completed or were terminated, 1 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 17 has an industry lead sponsor. The 10 most frequent:
CMH Multan Institute of Medical Sciences is the lead sponsor of 8 studies on the registry; 2 are open to participants now.
CMH Multan Institute of Medical Sciences has 1 study filed under Postpartum Hemorrhage — fewer than ten, so there is no comparison to draw.
3 of the studies in Postpartum Hemorrhage with a site in Pakistan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07550413Pak Emirates Military HospitalRole of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section | 2026-11 |
| NCT07845240Aziz Fatimah Medical & Dental College, FaisalabadEfficacy of Balloon Tamponade in Post-partum Hemorrhage Within 24 Hours After Delivery | 2027-04-01 |
| NCT07784478Khyber Girls Medical CollegeEffect of Oxytocin Bolus Versus Slow Infusion on Haemodynamic Stability During Caesarean Section Under Spinal Anaesthesia | 2027-04-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 17 studies in Postpartum Hemorrhage with a site in Pakistan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to determine whether giving oxytocin through the umbilical cord is more effective than giving it through a vein in reducing blood loss during the third stage of labor. The third stage of labor is the period between the birth of the baby and the delivery of the placenta. Excessive bleeding after delivery, known as postpartum hemorrhage, is a major cause of maternal illness and death worldwide. Oxytocin is commonly used to help the uterus contract and reduce bleeding after childbirth.
The main question this study aims to answer is:
Does intra-umbilical oxytocin reduce the average amount of blood loss during the third stage of labor compared with intravenous oxytocin?
Researchers will conduct a randomized controlled trial involving 60 women with uncomplicated pregnancies who are in spontaneous labor. Participants will be randomly assigned to one of two groups.
Participants in the first group will receive 10 IU oxytocin intravenously at the delivery of the baby's anterior shoulder. Participants in the second group will receive 10 IU oxytocin injected into the umbilical cord after the baby is delivered.
In both groups, the placenta will be delivered using controlled cord traction. Blood loss will be measured by collecting blood in a kidney tray and by weighing pre-weighed sanitary pads for the first 24 hours after delivery.
Researchers will compare the average blood loss between the two groups to determine which method of administering oxytocin is more effective in reducing postpartum bleeding.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Women in this group will receive 10 IU oxytocin administered intravenously at the delivery of the anterior shoulder of the baby during the third stage of labor.
Drug: Oxytocin after delivery
Women in this group will receive 10 IU oxytocin administered through the umbilical vein after delivery of the baby during the third stage of labor.
Drug: Intraumbilical oxytocin
10 IU oxytocin diluted in normal saline administered slowly via intravenous route at the time of delivery of the anterior shoulder to facilitate uterine contraction and reduce blood loss.
10 IU oxytocin diluted in 10 mL normal saline injected into the umbilical vein approximately 2 cm from the introitus after delivery of the baby, with the solution gently milked toward the placental insertion to promote placental separation and reduce blood loss.
Mean Blood Loss During the Third Stage of Labor and Within the First 24 Hours After Vaginal Delivery
The average amount of blood lost after delivery will be measured in milliliters. Blood loss will be collected in a kidney tray immediately after delivery and quantified using a graduated cylinder. Additional blood loss during the first 24 hours postpartum will be measured using pre-weighed sanitary pads (1 gram weight increase = 1 mL blood loss).
Time frame: From delivery of the baby until 24 hours postpartum
Plan to share: No
No publications or documents are linked to this record.
Ran from Aug 2025 to primary completion in Feb 2026, 5 months.
Of 28 non-industry phase 4 interventional studies under Postpartum Hemorrhage, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 20. This study's 5 months is below that.
Counting every sponsor, half of 29 studies reached it within 12 months; a quarter within 10 and three quarters within 20.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
CMH Multan Institute of Medical Sciences